39 research outputs found
Vertically Cobalt Nanoplate Arrays Based on One-Step Electrochemical Growth and Their Magnetic Properties
A cobalt nanoplate array (Co NPA) directly grown on a
copper substrate
by the one-step electrodeposition method is synthesized without any
template. Most of the nanoplates with a height of âŒ350 nm and
length of up to several micrometers stand vertically on the copper
substrate. The as-prepared cobalt nanoplates have the {100} crystal
facets as the basal plane. By adjusting the electroplating conditions,
the morphology and size of the cobalt nanocrystal can be modulated.
Owing to the interesting anisotropic nanostructures, remarkable magnetic
anisotropy is obtained on the Co NPA. In addition, the cobalt nanoplates
are demonstrated to show enhanced magnetic properties compared with
other cobalt nanostructures
Confirming induction of the severe acute pancreatitis model.
<p>Assessment of pancreatic injury by HE staining. Pancreatitis was induced by pancreatic-ductal perfusion with 5% Sodium taurocholate. All rats were sacrificed at 24 h after disease model initiation. A: A typical photomicrographs of HE stained tissue obtained from control rat. B: A photomicrograph of pancreatic injury which includes pancreatic edema, neutrophil infiltration, necrosis and hemorrhage.</p
Reverse the polarization of liver macrophages by IL-4 and Treg in vitro.
<p>Liver macrophages were obtained from at 24 h after SAP model initiation. In vitro, macrophages were respectively treated with PBS, IL-4 (10 ng/ml) or Treg (macrophages: Treg â2â¶1) for 8 hour (S+PBS, S+IL-4, S+Treg group). The M1/M2 polarization was assessed using real-time PCR and immunofluorescence. A: mRNA level of M1 markers in the macrophages. B: mRNA level of M2 markers in the macrophages. C: Immunofluorescence examination of the polarization of macrophages. The significance of differing mRNA levels was analyzed while comparing with the CTRL group. Error bars indicate the mean ±S.E. *p<0.05, **p<0.01, ***p<0.001.</p
Data_Sheet_1_RETRACTED: Oral Administration of Brain Protein Combined With Probiotics Induces Immune Tolerance Through the Tryptophan Pathway.docx
Excessive inflammation leads to secondary immune damage after traumatic brain injury (TBI). The intestinal mucosa is a key component of immune tolerance due to gut-brain axis regulation, but the curative effect is not optimal. Intestinal dysfunction impairs the establishment of immune tolerance in patients with TBI. Therefore, we orally administered brain protein (BP) combined with probiotics to induce immune tolerance and explored the mechanism by which the homeostasis of the microbiota contributes to the enhancement of curative effects by BPs. Herein, we demonstrated that patients with TBI and surgical brain injury (SBI) models of rats had obvious dysbiosis. Notably, the intestinal barrier, proinflammatory cytokines, and activation of microglia demonstrated that excessive inflammatory damage was better controlled in the combined group (oral administration of BP combined with probiotics) than in the BP group (oral administration of BP). Fundamentally, tandem mass tag (TMT)-based quantitative proteomics analysis revealed that BP and probiotics preferentially affect Try-related pathways. A series of experiments further confirmed that Indoleamine 2,3 dioxygenase (IDO)/Kynurenine (Kyn)/Aryl hydrocarbon receptor (AhR) expression was high in the BP group, while Tryptophan hydroxylase 1(TpH1)/5-hydroxytryptamine (5-HT) only changed in the combined group. This study suggests that probiotics can enhance the efficacy of oral BP-induced immune tolerance through the Try pathway.</p
Treg cells reversed the polarization of Liver macrophages longer than IL-4 treatment.
<p>In vitro, macrophages were treated with IL-4 (10 ng/ml) or Treg (macrophages: Treg â2â¶1) for 4, 8 and 16 hour. The polarization of M1/M2 was assessed using real time PCR and immunofluorescence. A: mRNA level of M1 markers in the macrophages. B: mRNA level of M2 markers in the macrophages. The significance of differing mRNA levels was analyzed while comparing the two groups in the same time point using the indifferent T-test. Error bars indicate the mean ±S.E. *p<0.05.</p
Identification of regulatory T cells and liver macrophages using flow cytometry.
<p><b>A:</b> liver macrophages were identified as CD11b/c positive cells after primary culture for 24 hours. <b>B:</b> The purity of Treg cells was examined after isolation using magnetic beads.</p
Table_1_Global research trends and hotspots on glioma stem cells.docx
BackgroundGlioma stem cells (GSCs) are a sub-population of cancer stem cells with capacity of self-renewal and differentiation. Accumulated evidence has revealed that GSCs were shown to contribute to gliomagenesis, distant metastasis as well as the resistance to radiotherapy and chemotherapy. As a result, GSCs were regarded as a promising therapeutic target in human glioma. The purpose of our study is to identify current state and hotspots of GSCs research by analyzing scientific publications through bibliometric methods.MethodsAll relevant publications on GSCs during 2003-2021 were extracted from the Science Citation Index Expanded of Web of Science Core Collection (WoSCC), and related information was collected and analyzed using Microsoft Excel 2016, GraphPad Prism 8 and VOSviewer software.ResultsA total of 4990 papers were included. The United States accounted for the largest number of publications (1852), the second average citations per item (ACI) value (67.54) as well as the highest H-index (157). Cancer Research was the most influential journal in this field. The most contributive institution was League of European Research Universities. RICH JN was the author with the most publications (109) and the highest H-index (59). All studies were clustered into 3 groups: âglioma stem cell propertiesâ, âcell biological propertiesâ and âoncology therapyâ. The keywords âidentificationâ, âCD133â and âside populationâ appeared earlier with the smaller average appearing years (AAY), and the keywordsâradiotherapyâ and âchemotherapyâ had the latest AAY. The analysis of top cited articles showed that âtemozolomideâ, âepithelial-mesenchymal transitionâ, and âimmunotherapyâ emerged as new focused issues.ConclusionThere has been a growing number of researches on GSCs. The United States has always been a leading player in this domain. In general, the research focus has gradually shifted from basic cellular biology to the solutions of clinical concerns. âTemozolomide resistanceâ, âepithelial-mesenchymal transitionâ, and âimmunotherapyâ should be given more attention in the future.</p
DataSheet_1_A cuproptosis-related genes signature associated with prognosis and immune cell infiltration in osteosarcoma.csv
Osteosarcoma (OS) is one of the most prevalent primary bone tumors at all ages of human development. The objective of our study was to develop a model of Cuproptosis-Related Genes (CRGs) for predicting prognosis in OS patients. All datasets of OS patients were obtained from the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) database and Gene Expression Omnibus (GEO) database. We obtained the gene set (81 CRGs) related to cuproptosis by accessing the database and previous literature. All the CRGs were analyzed by univariate COX regression, least absolute shrinkage and selection operator (LASSO) COX regression analysis to screen for CRGs associated with prognosis in OS patients. Then these CRGs were used to construct a prognostic signature, which was further verified by independent cohort (GSE21257) and clinical correlation analysis. Afterward, to identify underlying mechanisms, Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were used for the high-risk group by using the GSEA method. The association between the prognostic signature and 28 types of immune infiltrating cells in the tumor microenvironment was assessed. Ultimately, Lipoic Acid Synthetase (LIAS) (HR=0.632, P=0.004), Lipoyltransferase 1 (LIPT1) (HR=0.524, P=0.011), BCL2 Like 1 (BCL2L1/BCL-XL) (HR=0.593, P=0.022), and Pyruvate Dehydrogenase Kinase 1 (PDK1) (HR=0.662, P=0.025) were identified. Subsequently, they were used to calculate the risk score and build a prognostic model. In the training cohort, risk score (HR=1.878, P=0.003) could be considered as an independent prognostic factor, and OS patients with high-risk scores showed lower survival rates. Biological pathways related to substance metabolism and transport were enriched. There were significant differences in immune infiltrating cells in the tumor microenvironment. All in all, The CRGs signature is related to the tumor immune microenvironment and could be used as a credible predictor of the prognostic status in OS patients.</p
DataSheet_3_A cuproptosis-related genes signature associated with prognosis and immune cell infiltration in osteosarcoma.csv
Osteosarcoma (OS) is one of the most prevalent primary bone tumors at all ages of human development. The objective of our study was to develop a model of Cuproptosis-Related Genes (CRGs) for predicting prognosis in OS patients. All datasets of OS patients were obtained from the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) database and Gene Expression Omnibus (GEO) database. We obtained the gene set (81 CRGs) related to cuproptosis by accessing the database and previous literature. All the CRGs were analyzed by univariate COX regression, least absolute shrinkage and selection operator (LASSO) COX regression analysis to screen for CRGs associated with prognosis in OS patients. Then these CRGs were used to construct a prognostic signature, which was further verified by independent cohort (GSE21257) and clinical correlation analysis. Afterward, to identify underlying mechanisms, Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were used for the high-risk group by using the GSEA method. The association between the prognostic signature and 28 types of immune infiltrating cells in the tumor microenvironment was assessed. Ultimately, Lipoic Acid Synthetase (LIAS) (HR=0.632, P=0.004), Lipoyltransferase 1 (LIPT1) (HR=0.524, P=0.011), BCL2 Like 1 (BCL2L1/BCL-XL) (HR=0.593, P=0.022), and Pyruvate Dehydrogenase Kinase 1 (PDK1) (HR=0.662, P=0.025) were identified. Subsequently, they were used to calculate the risk score and build a prognostic model. In the training cohort, risk score (HR=1.878, P=0.003) could be considered as an independent prognostic factor, and OS patients with high-risk scores showed lower survival rates. Biological pathways related to substance metabolism and transport were enriched. There were significant differences in immune infiltrating cells in the tumor microenvironment. All in all, The CRGs signature is related to the tumor immune microenvironment and could be used as a credible predictor of the prognostic status in OS patients.</p
DataSheet_2_A cuproptosis-related genes signature associated with prognosis and immune cell infiltration in osteosarcoma.csv
Osteosarcoma (OS) is one of the most prevalent primary bone tumors at all ages of human development. The objective of our study was to develop a model of Cuproptosis-Related Genes (CRGs) for predicting prognosis in OS patients. All datasets of OS patients were obtained from the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) database and Gene Expression Omnibus (GEO) database. We obtained the gene set (81 CRGs) related to cuproptosis by accessing the database and previous literature. All the CRGs were analyzed by univariate COX regression, least absolute shrinkage and selection operator (LASSO) COX regression analysis to screen for CRGs associated with prognosis in OS patients. Then these CRGs were used to construct a prognostic signature, which was further verified by independent cohort (GSE21257) and clinical correlation analysis. Afterward, to identify underlying mechanisms, Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were used for the high-risk group by using the GSEA method. The association between the prognostic signature and 28 types of immune infiltrating cells in the tumor microenvironment was assessed. Ultimately, Lipoic Acid Synthetase (LIAS) (HR=0.632, P=0.004), Lipoyltransferase 1 (LIPT1) (HR=0.524, P=0.011), BCL2 Like 1 (BCL2L1/BCL-XL) (HR=0.593, P=0.022), and Pyruvate Dehydrogenase Kinase 1 (PDK1) (HR=0.662, P=0.025) were identified. Subsequently, they were used to calculate the risk score and build a prognostic model. In the training cohort, risk score (HR=1.878, P=0.003) could be considered as an independent prognostic factor, and OS patients with high-risk scores showed lower survival rates. Biological pathways related to substance metabolism and transport were enriched. There were significant differences in immune infiltrating cells in the tumor microenvironment. All in all, The CRGs signature is related to the tumor immune microenvironment and could be used as a credible predictor of the prognostic status in OS patients.</p